eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 19/12/2011
PIL Cervarix

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/12/2011 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
  • Change to dosage and administration
Updated on 07/03/2011 and displayed until 19/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 15/10/2010 and displayed until 07/03/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 13/10/2010 and displayed until 15/10/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 23/08/2010 and displayed until 13/10/2010
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
Updated on 18/01/2010 and displayed until 23/08/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 09/12/2009 and displayed until 18/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 29/10/2009 and displayed until 09/12/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 13/08/2009 and displayed until 29/10/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 22/05/2009 and displayed until 13/08/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 07/05/2009 and displayed until 22/05/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to storage instructions
Updated on 22/08/2008 and displayed until 07/05/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 08/04/2008 and displayed until 22/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 24/09/2007 and displayed until 08/04/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   human papillomavirus vaccine